A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy.
This article was originally published on MedicalXpress.com
Zepbound outperforms Wegovy in head-to-head weight loss study
You may also be interested in:
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
The Latest
5 Popular Supplements in Canada for Optimal Health and Wellness
As a health and wellness enthusiast, I have always been interested in the role of supplements in promoting optimal health. In Canada, there are many supplements available on the market, each with different benefits and […]
The Latest
PetVet Dx Revolutionizes Wildlife Conservation with AI and Molecular Diagnostics to Combat Incurable CWD in Deer and Elk
Chronic wasting disease (CWD), a devastating prion illness that affects North American cervids like deer and elk, poses a grave threat to their well-being and conservation efforts. Furthermore, it presents a potential risk of human […]
Read More:
-
Having school dinners rather than packed lunches could encourage picky-eating 13-year-olds to eat a wider variety of foods, according to a new University of Bristol-led [...]
-
Staffing challenges related to patient safety, physician well-being and workforce sustainability are a growing concern in the subspecialty of neonatology that call for reform.This article [...]
-
New findings from the Barwon Infant Study show the pattern of gene activity in babies’ noses is strongly linked to their risk of subsequent wheezing [...]
